A detailed history of Coyle Financial Counsel LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Coyle Financial Counsel LLC holds 5,890 shares of ABT stock, worth $760,222. This represents 0.22% of its overall portfolio holdings.

Number of Shares
5,890
Previous 6,064 2.87%
Holding current value
$760,222
Previous $691,000 3.62%
% of portfolio
0.22%
Previous 0.24%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

SELL
$111.93 - $119.39 $19,475 - $20,773
-174 Reduced 2.87%
5,890 $666,000
Q3 2024

Nov 08, 2024

SELL
$100.07 - $118.13 $10,907 - $12,876
-109 Reduced 1.77%
6,064 $691,000
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $11,937 - $13,184
109 Added 1.8%
6,173 $701,000
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $1,259 - $1,482
13 Added 0.21%
6,064 $614,000
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $24,190 - $28,007
-250 Reduced 3.97%
6,051 $585,000
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $28,505 - $34,760
250 Added 4.13%
6,301 $746,000
Q4 2021

Feb 07, 2022

SELL
$115.53 - $141.46 $3,812 - $4,668
-33 Reduced 0.54%
6,051 $852,000
Q2 2021

Aug 04, 2021

SELL
$105.79 - $124.53 $26,447 - $31,132
-250 Reduced 3.95%
6,084 $705,000
Q1 2021

May 10, 2021

BUY
$108.84 - $128.23 $27,210 - $32,057
250 Added 4.11%
6,334 $759,000
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $150,613 - $192,766
-1,967 Reduced 24.43%
6,084 $556,000
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $232,434 - $339,882
3,700 Added 85.04%
8,051 $635,000
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $259,083 - $288,420
3,300 Added 313.99%
4,351 $378,000
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $82,514 - $91,857
1,051 New
1,051 $378,000
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $8,209 - $9,903
-135 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $7,771 - $8,577
135 New
135 $8,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Coyle Financial Counsel LLC Portfolio

Follow Coyle Financial Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coyle Financial Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coyle Financial Counsel LLC with notifications on news.